Michael R Grever

8PUBLICATIONS
41CO-AUTHORS
Haematological tumoursInnate immunityCardiovascular medicine and haematology not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)Haematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 25, 2026
Outcomes of patients with chronic lymphocytic leukemia discontinuing covalent Bruton tyrosine kinase inhibitors due to adverse events.

|Oct 17, 2024
Incidence, description, and timing of serious and opportunistic infections in patients with hairy cell leukemia.

Nilesh Kapoor, Qiuhong Zhao, Andrew Stiff

|Aug 17, 2024
Atrial fibrillation burden and clinical outcomes following BTK inhibitor initiation.

John Alan Gambril, Sanam M Ghazi, Stephen Sansoterra

|Jun 08, 2024
Hairy cell leukemia variant and WHO classification correspondence Re: 5<sup>th</sup> edition WHO classification haematolymphoid tumors: lymphoid neoplasms.

Michael Grever, Leslie Andritsos, Mirela Anghelina

|Jul 14, 2022
Combined BCL2 and BTK inhibition in CLL demonstrates efficacy after monotherapy with both classes.

Jonathan M Hyak, Ying Huang, Kerry A Rogers

|Dec 28, 2020
The revised guidelines for the diagnosis and management of hairy cell leukaemia and the hairy cell leukaemia variant.

Xavier Troussard, Michael R Grever

Pageof 2

Frequent Collaborators

3 joint publications

Jennifer Woyach

3 joint publications

John C Byrd

2 joint publications

James S Blachly

2 joint publications

Narendranath Epperla